Wang:News: Difference between revisions
No edit summary |
|||
(One intermediate revision by the same user not shown) | |||
Line 5: | Line 5: | ||
<center><font face="lucida fax" style= "color:yellow" size="+2">'''Laboratory of Cancer Epigenomics'''</font></center> | <center><font face="lucida fax" style= "color:yellow" size="+2">'''Laboratory of Cancer Epigenomics'''</font></center> | ||
<br> | <br> | ||
<center><font face="lucida fax" style= "color:yellow" size="+1">'''Department of | <center><font face="lucida fax" style= "color:yellow" size="+1">'''Department of Cancer Biology and Genetics, The Ohio State University'''</font> | ||
<br> | <br> | ||
[[Wang | <font face="lucida fax" style="color:#ffffff" size="+1"> '''Home''' </font>]] | [[Wang | <font face="lucida fax" style="color:#ffffff" size="+1"> '''Home''' </font>]] | ||
Line 19: | Line 19: | ||
<td width="926"> | <td width="926"> | ||
==Current News in the Lab== | ==Current News in the Lab== | ||
'''March 2016''' | |||
<br> | |||
Ben earned his PhD in Biochemistry upon successful defense of his dissertation entitled "Looking beyond the androgen receptor for transcriptional drivers of prostate cancer." | |||
<br> | |||
'''January 2016''' | |||
<br> | |||
Ben and Dayong's paper entitled “Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence” was accepted by '''Nucleic Acids Research'''. | |||
<br> | |||
'''August 2015''' | '''August 2015''' | ||
<br> | <br> |
Latest revision as of 09:13, 1 July 2016
Current News in the LabMarch 2016
November 2010
July 2009
|